11th Annual Biomarkers Congress 2016

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 55 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

6 Interactive Streams:

  • Biomarkers in Discovery and Development
  • Developing Companion Diagnostics
  • Biomarker Discovery, Verification & Validation
  • Innovations In Biomarker Research
  • Biomarkers in Clinical Development & Diagnostics
  • Clinical Trials & Personalised Medicine

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Co-located with the 3rd Annual Biomarkers in Clinical Development Congress; focussing on the role of clinical biomarkers in clinical decision making. Presentations will include different therapeutic areas including: oncology, neuroscience, cardiology and immunology.

On day one the Biomarkers Congress will cover solutions to the most pressing drug discovery and development challenges such as advancing PK/PD modelling , implementing imaging biomarkers and identifying drug induced toxicity testing.

The challenge of translating biomarkers into companion diagnostics involves robust validation processes and hard-won regulatory approval. At our congress hear from industry leaders discussing the latest solutions and strategies for implementing companion diagnostics in drug-diagnostics co development.

Key solution providers and industry experts have recently joined forces in order to access highly sophisticated technologies and divide costs. On day two hear about the latest partnership and collaboration strategies from the top market players in the biomarker industry. Our expert panel will also share case studies on biomarker discovery, verification and validation including genomic, proteomic and metabolomics markers.

To build on the success of last year’s event, we are please to announce that the Biomarkers Congress will be co-located with the 3rd Annual Biomarkers in Clinical Development Congress, focussing on the role of biomarkers in clinical decision making, clinical diagnostics and clinical trial design. Industry leaders will discuss the importance of translating scientific innovations into patient benefits.

The Biomarkers Congress forms part of Oxford Global’s highly successful life science series. Upcoming events in the series include:



Sponsors 2016



Sponsors 2015




Media Partners